Electrical monitoring of infection biomarkers in chronic wounds using nanochannels

• Main Authors: Amor-Gutiérrez, O. (Author), Bassegoda, A. (Author), Escosura-Muñiz, A.D.L (Author), Iglesias-Mayor, A. (Author), Toyos-Rodríguez, C. (Author), Tzanov, T. (Author)
• Format: Article
• Language: English
• Published: Elsevier Ltd 2022
• Subjects: Alumina; Aluminum oxide; Biomarkers; Blockings; Chemical detection; Chronic wounds; Decision making; Developed countries; Diagnosis; Electrical monitoring; Electrochemical detection; ELectrochemical detection; Enzymes; Lysozyme; Nano channels; Nanochannels; Nanopores; Nano-porous alumina membranes; Patient treatment; Peptidoglycan; Peptidoglycans; Pore size; Sterics; Wound infection; Wound infections
• Online Access: View Fulltext in Publisher

 Chronic wounds represent an important healthcare challenge in developed countries, being wound infection a serious complication with significant impact on patients’ life conditions. However, there is a lack of methods allowing an early diagnosis of infection and a right decision making for a correct treatment. In this context, we propose a novel methodology for the electrical monitoring of infection biomarkers in chronic wound exudates, using nanoporous alumina membranes. Lysozyme, an enzyme produced by the human immune system indicating wound infection, is selected as a model compound to prove the concept. Peptidoglycan, a component of the bacterial layer and the native substrate of lysozyme, is immobilized on the inner walls of the nanochannels, blocking them both sterically and electrostatically. The steric blocking is dependent on the pore size (20–100 nm) and the peptidoglycan concentration, whereas the electrostatic blocking depends on the pH. The proposed analytical method is based on the electrical monitoring of the steric/electrostatic nanochannels unblocking upon the specific degradation of peptidoglycan by lysozyme, allowing to detect the infection biomarker at 280 ng/mL levels, which are below those expected in wounds. The low protein adsorption rate and thus outstanding filtering properties of the nanoporous alumina membranes allowed us to discriminate wound exudates from patients with both sterile and infected ulcers without any sample pre-treatment usually indispensable in most diagnostic devices for analysis of physiological fluids. Although size and charge effects in nanochannels have been previously approached for biosensing purposes, as far as we know, the use of nanoporous membranes for monitoring enzymatic cleavage processes, leading to analytical systems for the specific detection of the enzymes has not been deeply explored so far. Compared with previously reported methods, our methodology presents the advantages of no need of neither bioreceptors (antibodies or aptamers) nor competitive assays, low matrix effects and quantitative and rapid analysis at the point-of-care, being also of potential application for the determination of other protease biomarkers. © 2022 The Authors